Price history
¥786Latest+40.1%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
20.96How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
1.21How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
5.8%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥24bnShare price × number of shares. The value of the entire company.Equity ratio
30.8%The proportion of assets funded by money that does not have to be repaid.Operating margin
4.2%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
62.2%The average annual growth in sales over the past three years.What to watch next
Progress on Phase 2 of the Building 4 construction project at the Konosu Research Institute, scheduled to start in July 2026 and be completed in April 2027, and the corresponding achievement of monthly production capacity
July 2026 to April 2027Impact HighLikelihood Medium
Whether the organizational structure for the development and commercialization of the smart contact lens business progresses following the simplified absorption-type company split scheduled for 1 July 2026
July 2026Impact MediumLikelihood Medium
Whether the practical operation of the AI-based automated visual inspection system expands and improves the defect rate, inspection workload, or production stability
The second half of FY2026Impact MediumLikelihood Medium
Market penetration of new materials, such as Seed AirGrade 2week UV W-Moisture TORIC, and new colors, including circle and colored contact lenses
2026Impact MediumLikelihood Low
What to watch next
Who owns itTop holders total 55.9%
Listed holders 55.9%Everyone else 44.1%
Trustee of Managed Trust (A001): SMBC Trust Bank Ltd., Trust Account18.00%
Mizuho Trust & Banking Securities Custody Trust 070002614.27%
Nomura Trust and Banking Co., Ltd. (Trust Account 2052116)11.91%
三井住友信託銀行株式会社(信託口 甲1号)4.61%
浦壁 昌広2.04%
Japan Securities Finance Co.,Ltd.2.02%
シード社員持株会0.94%
井上 忠0.86%
2 other listed holders1.25%
| Holder | Ownership (%) |
|---|---|
| Trustee of Managed Trust (A001): SMBC Trust Bank Ltd., Trust Account | 18.00 |
| Mizuho Trust & Banking Securities Custody Trust 0700026 | 14.27 |
| Nomura Trust and Banking Co., Ltd. (Trust Account 2052116) | 11.91 |
| 三井住友信託銀行株式会社(信託口 甲1号) | 4.61 |
| 浦壁 昌広 | 2.04 |
| Japan Securities Finance Co.,Ltd. | 2.02 |
| シード社員持株会 | 0.94 |
| 井上 忠 | 0.86 |
| 2 other listed holders | 1.25 |
This company's documents
Filings
Timely disclosures
- 2026-10-14Notice Regarding the Results of the Public Tender Offer for Our Shares by Luxshare Precision Cayman Limited and Changes in Major Shareholders and Other Affiliated Companies
- 2026-10-06Notice Regarding the Setting of a Record Date for the Convocation of an Extraordinary General Meeting of Shareholders
- 2026-09-07(Correction) Notice of Correction to the Notice of Commencement of Tender Offer Following the Filing by Luxshare Precision Cayman Limited of an Amendment to Its Tender Offer Registration Statement
- 2026-08-26Notice concerning the commencement of a tender offer for the common shares of SEED CO.,LTD. (Securities Code: 7743) by Luxshare Precision Cayman Limited
- 2026-08-26Notice Regarding Our Opinion in Favor of, and Recommendation to Tender into, the Tender Offer for Our Shares by Luxshare Precision Cayman Limited
- 2026-08-26Notice Regarding Revision of the Year-End Dividend Forecast for the Fiscal Year Ending March 2027 (No Dividend) and Discontinuation of the Shareholder Benefit Program
- 2026-08-25Presentation Materials for the First Quarter Financial Results Briefing for the Fiscal Year Ending March 2027
- 2026-08-12Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (Japanese GAAP, Consolidated)
37 more
- 2026-07-13(Change to Disclosed Information) Partial change to the “Notice Concerning the Acquisition of Fixed Assets (Kōnosu Research Facility Building 4, Phase 2 Plan)”
- 2026-07-01Statutory Post-Event Disclosure Document (Company Split) (株式会社オキュデバイセズ)
- 2026-06-25Notice of Independent Officer Status
- 2026-06-23Notice of Personnel Changes
- 2026-06-02Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials
- 2026-05-29Statutory Advance Disclosure Documents (Company Split) (株式会社オキュデバイセズ)
- 2026-05-26Financial Results Presentation Materials for the Fiscal Year Ending March 2026
- 2026-05-25Notice Regarding Borrowing of Funds
- 2026-05-19Notice Regarding a Company Split (Simplified Absorption-Type Company Split)
- 2026-05-19Notice Regarding Dividend from Retained Earnings
- 2026-05-19Notice Concerning Changes in Officers
- 2026-05-12(Correction) Notice of Partial Correction to the "Summary of Financial Results for the Fiscal Year Ended March 2026 [Japanese GAAP] (Consolidated)"
- 2026-05-11Notice of an Update on Progress under the Medium-Term Management Plan and Key Issues Going Forward
- 2026-05-11Notice Regarding Differences Between the Full-Year Forecast and Actual Results for the Fiscal Year Ending March 2026
- 2026-05-11Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
- 2026-03-24Notice of Approval to Change Listing Market Segment to the Standard Market and Withdrawal of the “Plan for Compliance with the Prime Market Continued Listing Criteria”
- 2026-03-09Notice Regarding Organizational Changes and Personnel Changes
- 2026-02-25Third-Quarter Financial Results Briefing Materials for the Fiscal Year Ending March 2026
- 2026-02-09Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP]
- 2025-11-10FY2026 Second-Quarter (Interim) Financial Results Summary [Japanese GAAP] (Consolidated)
- 2025-08-08Notice of Acquisition of Fixed Assets (Kounosu Research Institute Building 4, Phase II Plan)
- 2025-08-08Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP]
- 2025-05-12Summary of Financial Results for the Fiscal Year Ended March 2025 [Japanese GAAP] (Consolidated)
- 2025-05-07Notice Regarding Revisions to Full-Year Earnings Forecast
- 2025-02-07Notice Regarding Revisions to Full-Year Earnings Forecast
- 2025-02-07Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 2025 [Japanese GAAP] (Consolidated)
- 2024-11-11(Update on Previously Disclosed Matter) Notice of Acquisition of Fixed Assets
- 2024-11-11Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ended March 2025 [Japanese GAAP] (Consolidated)
- 2024-08-06Summary of First-Quarter Financial Results for the Fiscal Year Ended March 2025 (Japanese GAAP, Consolidated)
- 2024-05-07Notice Regarding Revisions to Full-Year Earnings Forecasts and Recording of an Extraordinary Loss
- 2024-02-19Notice Regarding the Issuance and Offering of New Shares and Change in the Controlling Shareholder Other Than the Parent Company
- 2024-02-07Notice Regarding the Transfer of Business Between Consolidated Subsidiaries
- 2024-02-07Notice Regarding the Acquisition of Fixed Assets
- 2024-02-07Notice Regarding Revisions to Full-Year Earnings Forecast
- 2024-02-07Summary of Third-Quarter Financial Results for the Fiscal Year Ended March 2024 (Japanese GAAP, Consolidated)
- 2023-11-13Notice Regarding Revisions to Full-Year Earnings Forecast and Dividend Forecast
- 2023-05-08Notice Regarding Revisions to Full-Year Earnings Forecasts and Recording of an Extraordinary Loss
Threads
- 2026-10-14Prime Market Selection and Early Achievement of Listing Maintenance Criteria
- 2026-10-14Capital and Business Alliance with the Luxshare Group and Going Private Through a Tender Offer
- 2026-08-26Bringing “Japanese Seeds Reaching the World” to Life
- 2026-08-26Strengthening the Sales Strategy
- 2026-08-26Strengthening Production and Development Capabilities
- 2026-08-26Strengthening the Management Framework and Logistics and Delivery Quality
- 2026-08-26Overseas Business Expansion and Sales Channel Development
- 2026-08-26Balancing Stable Dividends with Retained Earnings and Business Investment
105 more
- 2026-08-26Long-term business growth through the acquisition of voting rights in SENSIMED AG
- 2026-08-26Promoting Talent Development and Diverse Workstyles
- 2026-08-26Building a Labor-Saving Production System
- 2026-08-26Discontinuation of the Shareholder Benefit Program
- 2026-08-26Maintaining the Current Management Structure and Stable Employment After Going Private
- 2026-08-26Transfer of the Taiwanese Subsidiary to La Holdings
- 2026-08-25Launch of New Products and Expanded Specifications for Existing Products
- 2026-08-25Expansion of production capacity and capabilities for new materials through the new building at the Konosu Research Institute
- 2026-08-25Growth in the Contact Lens Care Products Business
- 2026-08-25Intensifying competition over functionality, quality, pricing and distribution channels
- 2026-08-25Procurement Risk for Products, Materials and Raw Materials
- 2026-08-25Increase in Borrowings for Inventory Investment, Capital Equipment Additions and Accumulation of On-Hand Liquidity
- 2026-08-25Environmentally Responsible Manufacturing and BLUE SEED PROJECT
- 2026-08-25Consolidated Sales of ¥50 Billion and Establishing a Presence in the Global Contact Lens Market
- 2026-08-12Rebranding of the SEED 1dayPure Series
- 2026-06-25Transparent, Sound, Swift and Decisive Corporate Management
- 2026-06-22Growth through increasing domestic market share and developing overseas sales channels
- 2026-06-22Development of High-Performance Contact Lenses and Medical and Pharmaceutical Products
- 2026-06-22Development of contact lenses using new materials, including highly oxygen-permeable materials
- 2026-06-22Exposure to Overseas Political and Economic Conditions and Exchange-Rate Fluctuations
- 2026-06-22Foreign Exchange Risk in Import Transactions
- 2026-06-22Growth in Demand for Daily Disposable, Multifocal and Circle Lenses
- 2026-06-22Higher Revenue and Narrower Operating Loss in Other Businesses
- 2026-06-22Risk of higher borrowing costs due to rising interest rates
- 2026-06-22Risk of prolonged holding and deterioration of inventory
- 2026-06-22Risk of securing production personnel at the Konosu Research Institute
- 2026-06-22Achieving Carbon Neutrality by 2050
- 2026-06-22Risk of Sales Concentration Among Certain Customers and Policy Changes by Major Customers
- 2026-06-22Achieving a 20% proportion of women in management positions
- 2026-06-22Achieving a 75% Male Parental Leave Uptake Rate
- 2026-05-26Decrease in Operating Cash Flow Due to Investment in New Product Inventory
- 2026-05-11Rising Business Costs Due to Price Increases in the Logistics Industry
- 2025-11-10Strengthening European sales and technology development through the acquisition of a UK contact lens manufacturer
- 2025-11-10Promoting and Expanding Sales of Orthokeratology Lenses
- 2025-11-10Product Price Revisions in Response to Higher Costs and Yen Depreciation
- 2025-11-10Establishment of 上海実瞳健康科技有限公司 and Its Inclusion as a Consolidated Subsidiary
- 2025-11-10Joint-Delivery Pilot with Menicon
- 2025-11-10Consolidation of Vietnamese and Malaysian Subsidiaries
- 2025-11-10Completion of the liquidation of SEED Contact Lens Europe GmbH
- 2025-11-10Diversification of sales channels in China through the acquisition of 上海幻櫻商貿有限公司
- 2025-06-23Differentiation through domestic development capabilities, quality and safety
- 2025-06-23Preparation for clinical trials of drug-releasing soft contact lenses
- 2025-06-23Market Contraction and Structural Change Resulting from Japan’s Population Decline
- 2025-06-23Risk of leakage of personal information and research and development information
- 2025-06-23Strengthening the Internal Control, Compliance and Risk Management Framework
- 2025-06-23Accelerating Decision-Making and Business Execution Through the Executive Officer System
- 2025-06-23Contraction of the care products market due to the shift to disposable products
- 2025-06-23Impairment Risk for Property, Plant and Equipment, Goodwill and Investment Securities
- 2025-06-23Inventory Disposal Due to Manufacturing Equipment Malfunction at Konosu Research Institute
- 2025-06-23Reviewing the Rationale for Cross-Shareholdings and the Reduction Policy
- 2025-06-23Management of Climate-Related Risks and Opportunities Based on the TCFD Recommendations
- 2025-06-23Practical Implementation of an AI-Based Automated Visual Inspection System
- 2025-06-23Achieving an 80% female-to-male pay ratio among regular employees
- 2025-06-23Identifying and Periodically Reviewing シード's Materiality
- 2025-06-23Promoting Human Rights Policies and Human Rights Due Diligence
- 2025-06-23Formulation of a Multistakeholder Policy
- 2024-11-11Our Mission as a Comprehensive Manufacturer Specializing in Eye Care to Support “Seeing”
- 2024-11-11Construction of SEED's New Head Office Building
- 2023-11-13Demand, Operating and Overseas Supply Risks Arising from the COVID-19 Pandemic
- 2023-11-13Risk of weakening group capabilities due to investment decisions and subsidiary management
- 2023-06-28Risk of Production Interruptions Due to Disasters and Power Outages
- 2023-06-28Lower revenue and operating loss in the Eyewear Business
- 2023-06-28Risk to Continued Overseas Sales from Europe’s Transition to MDR
- 2023-06-28Successor Development and Succession Issues
- 2023-06-28Risk of tax burdens arising from changes in tax systems and differences of view with tax authorities
- 2023-06-28Labor Risks Concerning Employee Human Rights and Treatment and Foreign Technical Interns
- 2023-06-28Risk of Changes in Administrative Policy and Institutional Reform, and Differing Legal Interpretations
- 2023-02-13Improving production line utilization through OEM supply to major mass retailers
- 2023-02-13Establishment of 香港実瞳健康科技有限公司 and Inclusion as a Consolidated Subsidiary
- 2022-11-11First-Ever Publication of an Integrated Report and Communication of ESG Information
- 2022-08-08Administration of Executive Compensation Through Performance-Linked Compensation and Share-Purchase Compensation
- 2022-08-08Application of the Accounting Standard for Fair Value Measurement and Related Standards
- 2022-08-08Exclusion of the Eyewear Business from the Reportable Segments
- 2022-06-27Risks Relating to R&D Results and the Market Suitability of New Products
- 2022-06-27Product Defect and Product Liability Risks
- 2022-06-27Developing New Sales Channels for the Eyewear Business and Improving Business Profitability
- 2022-06-27Acquisition and Consolidation of Contact Lens Retail Business
- 2022-06-27Risk of a Decline in Corporate Value Due to Climate Change and Environmental Issues
- 2022-06-27Application of the Revenue Recognition Accounting Standard and Related Standards
- 2022-06-27Human Rights Issues Related to Business Activities
- 2022-06-27Reputational Risk from Social Media and Accident Response
- 2022-06-27Labor Risks Arising from Mental Health Issues
- 2022-02-10IR Video Distribution via the Official YouTube Channel
- 2021-11-12Change in Independent Auditor
- 2021-08-06Response to Stable Supply and Business Continuity During an Infectious Disease Outbreak
- 2020-08-07Transfer of sales operations for TORAY INDUSTRIES,INC.'s contact lens business
- 2020-06-26Risk of regulation and revocation of regulatory approvals and licenses under the Pharmaceuticals and Medical Devices Act and other laws and regulations
- 2020-06-26Strengthening the quality-control framework
- 2020-06-26Strengthening Technology and European Logistics Capabilities Through an Investment in Woehlk Contactlinsen GmbH
- 2020-06-26Impact of the Consumption Tax Increase Scheduled for October 2019 on Personal Consumption
- 2020-06-26Collection risk for convertible subordinated loans due to Sensimed AG’s failure to complete a capital increase
- 2020-02-07Capital Policy Through Share Buybacks
- 2020-02-07Limits of Intellectual Property Rights Protection and Infringement Risks
- 2020-02-07Significant Risk of Litigation
- 2020-02-07Lowering the Investment Unit and Expanding the Investor Base through a Stock Split
- 2020-02-07Maintaining buffer inventory in preparation for Brexit
- 2019-06-27Expansion of Contact Lens Care Products Centered on Southeast Asia
- 2019-06-27Medical Incident, Regulatory Change and Ophthalmology Clinic Recruitment Risks in the Retail Sales Business
- 2019-06-27Credit risk on trade receivables
- 2019-06-27Market Price Risk on Investment Securities
- 2019-06-27Liquidity Risk Associated with Payments on Borrowings and Other Obligations
- 2018-08-10Acquiring Land to Open a Childcare Facility
- 2017-02-10Business downsizing through the transfer of mobile phone division stores
- 2017-02-10Establishment of 株式会社アイスペース
- 2016-06-29Regulatory Approvals in China, Southeast Asia and Europe